AmBisome Monotherapy and Combination AmBisome–Miltefosine Therapy for the Treatment of Visceral Leishmaniasis in Patients Coinfected With Human Immunodeficiency Virus in India: A Randomized Open-Label, Parallel-Arm, Phase 3 TrialSakib Burza, Krishna Pandey, Alan de Lima Pereira et al.|Clinical Infectious Diseases|2022Cited by 53
Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, IndiaVishal Goyal, Fabiana Alves, Vidya Nand Rabi Das et al.|PLoS neglected tropical diseases|2020Cited by 37
PKDL Development after Combination Treatment with Miltefosine and Paromomycin in a Case of Visceral Leishmaniasis: First Ever Case ReportPriya Krishna, Jorge Alvar, ey et al.|Unknown|2018Cited by 3
A Randomized Trial of AmBisome Monotherapy and Combination of AmBisome and Miltefosine for the Treatment of Visceral Leishmaniasis in HIV-Positive Patients in IndiaSakib Burza, Pradeep Das, Krishna Pandey et al.|Unknown|2019Cited by 1